Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
Flourié B, Hagège H, Tucat G, Maetz D, Hébuterne X, Kuyvenhoven JP, Tan TG, Pierik MJ, Masclee AA, Dewit O, Probert CS, Aoucheta D; MOTUS study investigators. Flourié B, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2013 Apr;37(8):767-75. doi: 10.1111/apt.12266. Epub 2013 Mar 4. Aliment Pharmacol Ther. 2013. PMID: 23451806 Free article. Clinical Trial.
Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor.
Terlevich A, Hearing SD, Woltersdorf WW, Smyth C, Reid D, McCullagh E, Day A, Probert CS. Terlevich A, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2003 May 15;17(10):1325-9. doi: 10.1046/j.1365-2036.2003.01567.x. Aliment Pharmacol Ther. 2003. PMID: 12755846 Free article.
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
Creed TJ, Norman MR, Probert CS, Harvey RF, Shaw IS, Smithson J, Anderson J, Moorghen M, Gupta J, Shepherd NA, Dayan CM, Hearing SD. Creed TJ, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2003 Jul 1;18(1):65-75. doi: 10.1046/j.1365-2036.2003.01639.x. Aliment Pharmacol Ther. 2003. PMID: 12848627 Free article. Clinical Trial.
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, Midhagen G, Rademaker J, Foldager M. Marteau P, et al. Among authors: probert cs. Gut. 2005 Jul;54(7):960-5. doi: 10.1136/gut.2004.060103. Gut. 2005. PMID: 15951542 Free PMC article. Clinical Trial.
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
Mansfield JC, Parkes M, Hawthorne AB, Forbes A, Probert CS, Perowne RC, Cooper A, Zeldis JB, Manning DC, Hawkey CJ. Mansfield JC, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2007 Aug 1;26(3):421-30. doi: 10.1111/j.1365-2036.2007.03385.x. Aliment Pharmacol Ther. 2007. PMID: 17635377 Free article. Clinical Trial.
Review article: cytomegalovirus and inflammatory bowel disease.
Sager K, Alam S, Bond A, Chinnappan L, Probert CS. Sager K, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2015 Apr;41(8):725-33. doi: 10.1111/apt.13124. Epub 2015 Feb 16. Aliment Pharmacol Ther. 2015. PMID: 25684400 Free article. Review.
243 results